Neuropsychiatric aspects of parkinson’s disease-Reference-Cited by-同舟云学术

Neuropsychiatric aspects of parkinson’s disease

Published:1999-06 Issue:1 Volume:1 Page:61-68
ISSN:1523-3812
Container-title:Current Psychiatry Reports
language:en
Short-container-title:Curr Psychiatry Rep

Author:

Aarsland Dag,Karlsen Karen

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11920-999-0011-3.pdf

Reference61 articles.

1. Litvan I, MacIntyre A, Goetz CG, et al.: Accurcay of the clinical diagnoses of Lewy body disease, Parkinson’s disease, and dementia with Lewy bodies. Arch Neurol 1998, 55:969–978. An interesting paper comparing the clinical diagnoses with autopsy findings in subjects with PD, dementia with Lewy bodies, and controls. The paper provides important background information regarding the studies of neuropsychiatric symptoms in PD.

2. Cummings JL, Mega M, Gray K, et al.: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308–2314.

3. Aarsland D, Larsen JP, Lim NG, et al.: The spectrum of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry, in press.

4. Marder K, Tang MX, Cote L, et al.: The frequency and associated risk factors for dementia in patients with Parkinson’s disease. Arch Neurol 1995, 52:695–701.

5. Tison F, Dartigues JF, Auriacombe S, et al.: Dementia in Parkinson’s disease: a population-based study in ambulatory and institutionalized individuals. Neurology 1995, 45:705–707.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Online cognitive testing in Parkinson’s disease: advantages and challenges;Frontiers in Neurology;2024-04-08

2. Integrating virtual reality and exergaming in cognitive rehabilitation of patients with Parkinson disease: a systematic review of randomized controlled trials;European Journal of Physical and Rehabilitation Medicine;2023-01

3. Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden;Brain Sciences;2022-01-11

4. Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats;Neural Plasticity;2021-07-28

5. Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice;Expert Review of Neurotherapeutics;2020-05-03